The bacteria which live in our gut play important roles in our health; they influence how the immune system works, how patients react and respond to drugs, and how diseases progress. However multidrug resistant bacteria can disrupt the delicate microbial balance increasing the risk of persistent infections and immune dysfunction.
Faecal or Intestinal Microbiota Transplant is a therapy that restores healthy gut bacteria by transferring stool from screened donors to patients, offering a promising approach to combat antimicrobial resistance and improve patient outcomes. In this seminar, two experts will talk about their research and answer your questions:
Dr Ben Mullish is a Senior Clinical Research Fellow in the Division of Digestive Diseases (Department of Metabolism, Digestion and Reproduction) at Imperial College London, and Honorary Consultant in Hepatology and Gastroenterology at Imperial College Healthcare NHS Trust. Dr Mullish will talk about his research on C difficile infection and the challenges of setting up an Intestinal Microbiota Transplant service.
Dr Frances Davies is an Academic Clinical Microbiologist in the Department of Infectious Diseases at Imperial College London and a Consultant Microbiologist at Imperial College Healthcare NHS Trust. Dr Davies will talk about her research on Intestinal Microbiota Transplants to treat multidrug resistant bacteria in transplant patients and in patients with recurrent urinary tract infections.